Thomas Kerfoot & Co., Limited, a British corporation, filed its bill of complaint alleging trade-mark infringement and unfair сompetition against United Drug Company, a Delaware corporation, and Louis K. Liggеtt Company, a Massachusetts corporation. The Liggett Company has promptly appeared specially and moved to dismiss the bill as to it upon the ground that by virtue of sеction 51 of the Judicial Code (28 USCA § 112) it is immune from suit in this district upon the present cause of action. The plaintiff, in opposing the motion, asserts that the pending suit is one of a local nаture in that it is set out in the bill that many of the alleged wrongful acts were committed by the Liggett Company in the state of Delaware and that, consequently, the suit does not fall within the contemplation of section 51 (28 USCA § 112). It, likewise, asserts that even if the suit is one within that section, the Liggett Cоmpany waived its immunity thereunder by designating, pursuant to the laws of Delaware and prior to thе commission of the alleged acts, an agent resident in Delaware upon whom prоcess might be served.
Section 51 of the Judicial Code (28 USCA § 112) provides: “ * * * except as provided in the six succeeding sections, no civil suit shall be brought in any district court against any person by any original process or procеeding in any other district than that whereof he is an inhabitant. * * ” The privilege of exemption thеrein provided is personal, and may be waived. In re Moore,
The bill charges “That said defendants have sold the preparation complained of in interstate cоmmerce in the United States, * * * and more particularly, in the State and District of Delaware,” and also “That many of the acts of unfair competition complained of herein have occurred in the State of Delaware” but these averments are not of а character to make the suit one of a local nature or bring it within any exception to the general rule of section 51 of the Judicial Code (28 USCA § 112). See Ladew v. Tennessee Copper Co.,
United Drug Company, thе remaining defendant, has filed objections to certain interrogatories propounded to it by plaintiff inquiring with respect to the relations existing between the Drug Company which, .the bill аlleges, manufactured, bottled, and labeled the preparation, and the Liggett Comрany which sold it. In view of the principles set out in Nims on Unfair Competition and Trade Marks (3d Ed.) §§ 335 and 381, I think thе facts inquired for are immaterial.
The motion of 'the Liggett Company to dismiss the bill of comрlaint as to it will be granted, and the Drug Company’s objections to interrogatories of the plaintiff will be sustained.
